‘Clear’ downtrends of major hypertension treatments
Downtrends of major hypertension treatments have become obvious.
It was observed only did 3 of 15 antihypertensive drugs have higher outpatient prescriptions in the 3rd quarter than the record of the last year.
According to the UBIST’s data on the 25th, the top antihypertensive drug was Boehrin...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
